Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Nature Communications|September 23, 2015
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathwaysHeather J Cordell, Younghun Han, George F Mells, et al.
Annals of Hepatology|August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinomaLouisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Journal of Hepatology|June 23, 2022
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic targetGiorgia Alvisi, Alberto Termanini, Cristiana Soldani, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|April 16, 2014
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosisCarlo Selmi, Francesca Cavaciocchi, Ana Lleo, et al.
Nature Communications|September 23, 2015
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathwaysHeather J Cordell, Younghun Han, George F Mells, et al.
Annals of Hepatology|August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinomaLouisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Gastroenterology|August 12, 2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid TherapyWillem J Lammers, Gideon M Hirschfield, Christophe Corpechot, et al.
Journal of Hepatology|June 23, 2022
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic targetGiorgia Alvisi, Alberto Termanini, Cristiana Soldani, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growthAloña Agirre-Lizaso, Maider Huici-Izagirre, Colm J O'Rourke, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Pageof 21